Partner Lee Rosebush and Associate Marc Wagner will take part in a panel titled “Compounding: Demystifying Pharmacy Compounding and 503B Outsourcing” at INTERPHEX, which runs April 21-23, 2026, in New York, New York. The session will examine the legal, regulatory and operational differences between 503A and 503B facilities, including their roles in patient care, market
Latest Post
More Posts
Navigating Legal and Regulatory Risks in Direct-to-Consumer Pharmacy Models
Lee Rosebush Takes Part in Panel at Advertising and Promotion for Medical Products Conference
Lee Rosebush, Marc Wagner Present at NASP 2025 Annual Meeting and Expo
Lee Rosebush Speaks About Tirzepatide at Compounding Pharmacy Compliance Event
Lee Rosebush, Marc Wagner Represent SCA Pharmaceuticals in Litigation Against FDA
FDA Authorizes Marketing of Zyn Nicotine Pouches
The FDA’s New Definition of ‘Healthy’: A Step Forward, or a Step Too Far?
FDA Advances Proposal To Lower Nicotine in Cigarettes
Federal Court Blocks FDA’s Graphic Cigarette Warning Rule: The Limits of Regulatory Authority
Subscribe: Subscribe via RSS